• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

L 抗原家族成员 3 可作为皮肤黑色素瘤临床结局和免疫浸润的预后生物标志物。

L Antigen Family Member 3 Serves as a Prognostic Biomarker for the Clinical Outcome and Immune Infiltration in Skin Cutaneous Melanoma.

机构信息

Department of Pediatric Surgery, The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325027 Zhejiang Province, China.

Department of Children's Health Care, The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325027 Zhejiang Province, China.

出版信息

Biomed Res Int. 2021 Mar 18;2021:6648182. doi: 10.1155/2021/6648182. eCollection 2021.

DOI:10.1155/2021/6648182
PMID:33829062
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8000545/
Abstract

L Antigen Family Member 3 (LAGE3) is an important RNA modification-related protein. Whereas few studies have interrogated the LAGE3 protein, there is limited data on its role in tumors. Here, we analyzed and profiled the LAGE3 protein in skin cutaneous melanoma (CM) using TCGA, GTEx, or GEO databases. Our data showed an upregulation of LAGE3 in melanoma cell lines compared to normal skin cell lines. Besides, the Kaplan-Meier curves and Cox proportional hazard model revealed that LAGE3 was an independent survival indicator for CM, especially in metastatic CM. Moreover, LAGE3 was negatively associated with multiple immune cell infiltration levels in CM, especially CD8 T cells in metastatic CM. Taken together, our study suggests that LAGE3 could be a potential prognostic biomarker and might be a potential target for the development of novel CM treatment strategies.

摘要

L 抗原家族成员 3(LAGE3)是一种重要的 RNA 修饰相关蛋白。虽然很少有研究探讨 LAGE3 蛋白,但关于其在肿瘤中的作用的数据有限。在这里,我们使用 TCGA、GTEx 或 GEO 数据库分析和描绘了皮肤黑色素瘤(CM)中的 LAGE3 蛋白。我们的数据显示,与正常皮肤细胞系相比,LAGE3 在黑色素瘤细胞系中上调。此外,Kaplan-Meier 曲线和 Cox 比例风险模型表明,LAGE3 是 CM 的独立生存指标,特别是在转移性 CM 中。此外,LAGE3 与 CM 中多种免疫细胞浸润水平呈负相关,特别是转移性 CM 中的 CD8 T 细胞。总之,我们的研究表明,LAGE3 可能是一种潜在的预后生物标志物,可能是开发新型 CM 治疗策略的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f5a/8000545/844f9c40ebc2/BMRI2021-6648182.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f5a/8000545/c2cb83e19ecc/BMRI2021-6648182.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f5a/8000545/5dc727625beb/BMRI2021-6648182.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f5a/8000545/fbc8e39f9749/BMRI2021-6648182.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f5a/8000545/13da558fb059/BMRI2021-6648182.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f5a/8000545/1565283bb1d9/BMRI2021-6648182.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f5a/8000545/0fc08e424f7b/BMRI2021-6648182.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f5a/8000545/8291e77ded85/BMRI2021-6648182.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f5a/8000545/844f9c40ebc2/BMRI2021-6648182.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f5a/8000545/c2cb83e19ecc/BMRI2021-6648182.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f5a/8000545/5dc727625beb/BMRI2021-6648182.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f5a/8000545/fbc8e39f9749/BMRI2021-6648182.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f5a/8000545/13da558fb059/BMRI2021-6648182.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f5a/8000545/1565283bb1d9/BMRI2021-6648182.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f5a/8000545/0fc08e424f7b/BMRI2021-6648182.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f5a/8000545/8291e77ded85/BMRI2021-6648182.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f5a/8000545/844f9c40ebc2/BMRI2021-6648182.008.jpg

相似文献

1
L Antigen Family Member 3 Serves as a Prognostic Biomarker for the Clinical Outcome and Immune Infiltration in Skin Cutaneous Melanoma.L 抗原家族成员 3 可作为皮肤黑色素瘤临床结局和免疫浸润的预后生物标志物。
Biomed Res Int. 2021 Mar 18;2021:6648182. doi: 10.1155/2021/6648182. eCollection 2021.
2
Identification of Prognostic Biomarkers of Cutaneous Melanoma Based on Analysis of Tumor Mutation Burden.基于肿瘤突变负担分析的皮肤黑色素瘤预后生物标志物的鉴定。
Comput Math Methods Med. 2020 Nov 16;2020:8836493. doi: 10.1155/2020/8836493. eCollection 2020.
3
Data mining of immune-related prognostic genes in metastatic melanoma microenvironment.免疫相关预后基因在转移性黑色素瘤微环境中的数据挖掘。
Biosci Rep. 2020 Nov 27;40(11). doi: 10.1042/BSR20201704.
4
Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.皮肤原发性黑色素瘤中的肿瘤相关B细胞与改善的临床结局
Hum Pathol. 2016 Aug;54:157-64. doi: 10.1016/j.humpath.2016.03.022. Epub 2016 Apr 21.
5
A novel prognostic biomarker LCP2 correlates with metastatic melanoma-infiltrating CD8 T cells.一种新型预后生物标志物 LCP2 与转移性黑色素瘤浸润的 CD8 T 细胞相关。
Sci Rep. 2021 Apr 28;11(1):9164. doi: 10.1038/s41598-021-88676-9.
6
Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.利用免疫相关基因对signature 预测黑色素瘤的临床结局。
PLoS One. 2020 Oct 8;15(10):e0240331. doi: 10.1371/journal.pone.0240331. eCollection 2020.
7
PMEL as a Prognostic Biomarker and Negatively Associated With Immune Infiltration in Skin Cutaneous Melanoma (SKCM).PMEL 作为一种预后生物标志物,与皮肤黑色素瘤(SKCM)中的免疫浸润呈负相关。
J Immunother. 2021;44(6):214-223. doi: 10.1097/CJI.0000000000000374.
8
LAGE3 correlates with tumorigenic immune infiltrates in the clear cell renal cell carcinoma microenvironment.LAGE3 与透明细胞肾细胞癌微环境中的致瘤性免疫浸润相关。
Int Immunopharmacol. 2020 Oct;87:106793. doi: 10.1016/j.intimp.2020.106793. Epub 2020 Jul 17.
9
Prediction of clinical prognosis in cutaneous melanoma using an immune-related gene pair signature.基于免疫相关基因对signature 预测皮肤黑色素瘤的临床预后
Bioengineered. 2021 Dec;12(1):1803-1812. doi: 10.1080/21655979.2021.1924556.
10
Development and Validation of the B Cell-Associated Fc Receptor-like Molecule-Based Prognostic Signature in Skin Cutaneous Melanoma.基于 B 细胞相关 Fc 受体样分子的皮肤黑色素瘤预后标志物的建立与验证。
Biomed Res Int. 2020 Aug 22;2020:8509805. doi: 10.1155/2020/8509805. eCollection 2020.

引用本文的文献

1
Detecting Deleterious Recessive Variants in Large Yellow Croaker Using Data from 7337 Individuals.利用7337个个体的数据检测大黄鱼中的有害隐性变异
Mar Biotechnol (NY). 2025 Jun 26;27(4):105. doi: 10.1007/s10126-025-10486-1.
2
DIRAS2 Is a Prognostic Biomarker and Linked With Immune Infiltrates in Melanoma.DIRAS2是一种预后生物标志物,与黑色素瘤中的免疫浸润相关。
Front Oncol. 2022 May 16;12:799185. doi: 10.3389/fonc.2022.799185. eCollection 2022.
3
Analysis of L Antigen Family Member 3 as a Potential Biomarker and Therapeutic Target Associated With the Progression of Hepatocellular Carcinoma.

本文引用的文献

1
Identification of the prognostic and immunotherapeutic potential of L antigen family member 3 in malignant pleural mesothelioma.鉴定L抗原家族成员3在恶性胸膜间皮瘤中的预后及免疫治疗潜力。
Clin Transl Med. 2020 Nov;10(7):e207. doi: 10.1002/ctm2.207.
2
Identification of prognostic mRNAs in metastatic cutaneous melanoma.鉴定转移性皮肤黑色素瘤的预后 mRNA。
Melanoma Res. 2020 Dec;30(6):543-547. doi: 10.1097/CMR.0000000000000697.
3
LAGE3 correlates with tumorigenic immune infiltrates in the clear cell renal cell carcinoma microenvironment.
L抗原家族成员3作为与肝细胞癌进展相关的潜在生物标志物和治疗靶点的分析
Front Oncol. 2022 Mar 31;12:813275. doi: 10.3389/fonc.2022.813275. eCollection 2022.
4
Correlation of LAGE3 with unfavorable prognosis and promoting tumor development in HCC via PI3K/AKT/mTOR and Ras/RAF/MAPK pathways.LAGE3 与 HCC 不良预后相关,并通过 PI3K/AKT/mTOR 和 Ras/RAF/MAPK 通路促进肿瘤发展。
BMC Cancer. 2022 Mar 21;22(1):298. doi: 10.1186/s12885-022-09398-3.
5
LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway.LAGE3 通过促进 JNK 和 ERK 信号通路促进肝癌细胞的增殖、迁移和侵袭,抑制细胞凋亡。
Cell Mol Biol Lett. 2021 Nov 27;26(1):49. doi: 10.1186/s11658-021-00295-4.
LAGE3 与透明细胞肾细胞癌微环境中的致瘤性免疫浸润相关。
Int Immunopharmacol. 2020 Oct;87:106793. doi: 10.1016/j.intimp.2020.106793. Epub 2020 Jul 17.
4
Upregulation of LAGE3 correlates with prognosis and immune infiltrates in colorectal cancer: A bioinformatic analysis.LAGE3 的上调与结直肠癌的预后和免疫浸润相关:一项生物信息学分析。
Int Immunopharmacol. 2020 Aug;85:106599. doi: 10.1016/j.intimp.2020.106599. Epub 2020 May 18.
5
Integrative analyses of the RNA modification machinery reveal tissue- and cancer-specific signatures.RNA 修饰机制的综合分析揭示了组织和癌症特异性特征。
Genome Biol. 2020 May 7;21(1):97. doi: 10.1186/s13059-020-02009-z.
6
Predicting the Risk of Melanoma Metastasis Using an Immune Risk Score in the Melanoma Cohort.在黑色素瘤队列中使用免疫风险评分预测黑色素瘤转移风险
Front Bioeng Biotechnol. 2020 Mar 31;8:206. doi: 10.3389/fbioe.2020.00206. eCollection 2020.
7
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
8
Identification of differentially expressed genes in non-small cell lung cancer.非小细胞肺癌中差异表达基因的鉴定
Aging (Albany NY). 2019 Dec 9;11(23):11170-11185. doi: 10.18632/aging.102521.
9
Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology.基于转录组的免疫肿瘤学细胞类型定量方法的综合评估。
Bioinformatics. 2019 Jul 15;35(14):i436-i445. doi: 10.1093/bioinformatics/btz363.
10
Identification of TP53RK-Binding Protein (TPRKB) Dependency in -Deficient Cancers.鉴定 - 缺陷型癌症中 TP53RK-Binding Protein (TPRKB) 依赖性。
Mol Cancer Res. 2019 Aug;17(8):1652-1664. doi: 10.1158/1541-7786.MCR-19-0144. Epub 2019 May 20.